Breast Cancer Connection

Clinical Trials 101: What They Are and What to Consider

October 12, 2022 Canadian Breast Cancer Network (CBCN) Episode 6
Breast Cancer Connection
Clinical Trials 101: What They Are and What to Consider
Show Notes

Knowing the basics of clinical trials – and how they differ from research studies – is important for understanding your options. In this episode, Dr. Stephen Chia answers common questions, offers guidance on what to consider before deciding to participate, and outlines a ‘day-in-the-life’ experience for those enrolled in a clinical trial. This podcast episode was supported by Hoffmann-La Roche Limited.

This podcast contains scientific information about compounds and uses that are investigational and have not been authorized for sale by Health Canada. The views and opinions expressed by Dr. Chia during this podcast are his own. Patients should consult their physician for any questions they may have regarding breast cancer treatment.

About Dr. Stephen Chia:
Dr. Chia is the head of clinical research at the BC Cancer Research Institute, a medical oncologist at BC Cancer Research – Vancouver, Professor of Medicine within the Department of Medicine at UBC and the Division Head for Medical Oncology, Department of Medicine, UBC.

Helpful links and resources:
For more information on available clinical trials in the area of breast cancer, visit

Check out the CBCN’s three-part series on clinical trials for more resources and in-depth information on this topic: 

Stay tuned for a future Breast Cancer Connection episode on overcoming roadblocks in cancer care while navigating a complex health system. If you missed them last year, check out our other Breast Cancer Connection episodes: 

About the Canadian Breast Cancer Network
CBCN is Canada’s leading patient-directed breast cancer health charity that voices the views and concerns of breast cancer patients through the promotion of information sharing, education, and advocacy activities. CBCN connects patients, caregivers, health care professionals, researchers, public health agencies and industry stakeholders to improve knowledge translation and promote optimal health outcomes for Canadians with breast cancer. Learn more at